Has Christine Frey received payments from drug or device companies?

Yes. Drug and device makers reported $3,617 in general payments to Christine Frey across 311 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christine Frey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christine Frey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christine Frey

Adult Health · Bellevue, WANPI 1659488518

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,111 of the $3,617 with a category attached, or 86.0%. 8 manufacturers reported payments, led by Amgen at 55.0% of the total. Among adult health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,617in general payments, 2019–2025

Across 311 payments — averaging $11.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
Johnson & Johnson$1K
AstraZeneca$169
Novartis$30
AbbVie$29
UCB, Inc.$29
plus $33 from 2 others

What the payments were for

Food & beverage$3,11186%
Education$50614%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	194	$1,989
Johnson & Johnson	109	$1,338
AstraZeneca	2	$169
Novartis	1	$30
AbbVie	2	$29
UCB, Inc.	1	$29
Aurinia Pharma U.S., Inc.	1	$20
E.r. Squibb & Sons, L.L.C.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Otezla$109

How this compares

$3,617 in reported general payments places this provider in the 90th percentile of 252 adult health providers in Washington.

See all adult health providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	26	$282,764
Enbrel SureclickEtanercept	21	$149,842
OlumiantBaricitinib	12	$31,762
Wellbutrin XlBupropion Hcl	12	$30,842
AdcircaTadalafil	11	$21,591
RexultiBrexpiprazole	11	$15,249
Bupropion XlBupropion Hcl	65	$4,757
Hydroxychloroquine Sulfate	119	$4,311
Lurasidone Hcl	11	$3,759
Lidocaine	20	$3,321
Trazodone Hcl	80	$2,825
Duloxetine Hcl	63	$1,800
Aripiprazole	24	$1,513
Np ThyroidThyroid,pork	22	$1,419
Colchicine	11	$1,026

Paid to pharmacies, not to this prescriber.

Other adult health in Bellevue

Amanda NortonBellevue$8K
Christina RedmondBellevue$2K
Michele YinglingBellevue$1K
George BaxterSeattle$868K
April WatkinsSeattle$101K
Ming Chi HsiaoTacoma$46K
Leslie SwansonSeattle$18K
Kindra Clark-SnustadSeattle$10K
Alexxia RichmondSnohomish$7K
Jonathan TurowskiMill Creek$7K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →